Regeneron Loses 23andMe Bid to TTAM Research Institute
23andMe FOUNDER AND FORMER CEO ANNE WOJCICKI has successfully retained control over her company by selling it to her nonprofit medical research firm TTAM Research Institute for $305 million. This followed bidding between TTAM Research Institute and Regeneron Pharmaceuticals, which previously announced it had entered into a purchasing agreement to acquire most of the assets […]
Regeneron Loses 23andMe Bid to TTAM Research Institute Read More »